Select your localized edition:

Close ×

More Ways to Connect

Discover one of our 28 local entrepreneurial communities »

Be the first to know as we launch in new countries and markets around the globe.

Interested in bringing MIT Technology Review to your local market?

MIT Technology ReviewMIT Technology Review - logo


Unsupported browser: Your browser does not meet modern web standards. See how it scores »

Biomedicine Archive

  • Gene Hunting in Canada

    Genizon is using the genetic homogeneity of French Canadians to find new drug targets – and redefine human disease.

  • A New Tool for Surgeons

    Mass spectrometry, a favorite analytical technique of chemists, may find a place in the operating room.

  • Spotting Alzheimer's Early

    A new type of PET imaging technique could eventually help doctors diagnose and head off the disease before symptoms appear.


  • Rapid Nano Molding

    Researchers are using a new all-purpose nano synthesis method to design cancer-fighting nanoparticles.

  • Proteins' Baby Pictures

    A technique for imaging freshly made proteins is giving researchers a unique window on the working of genes and cells.

  • Will the Bird Flu Jump to Humans?

    Scientists have new tools to predict how the virus might make the leap, but the move may be more difficult than they thought.

    1 comment

  • A One-Two Punch for Alzheimer's

    An enzyme has been identified that can target both major markers of Alzheimer’s, providing a new venue for drug development.

    1 comment

  • Cancer Breathalyzer

    SUNY researchers are working on a small, easy-to-use disease detector.



From the Archives


Introducing MIT Technology Review Insider.

Already a Magazine subscriber?

You're automatically an Insider. It's easy to activate or upgrade your account.

Activate Your Account

Become an Insider

It's the new way to subscribe. Get even more of the tech news, research, and discoveries you crave.

Sign Up

Learn More

Find out why MIT Technology Review Insider is for you and explore your options.

Show Me